The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing

Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome.

Bibliographic Details
Main Author: Mostafa, Arwa Mohamed Amin
Format: Thesis
Language:English
Published: 2016
Subjects:
Online Access:http://eprints.usm.my/36317/
http://eprints.usm.my/36317/1/24Pages_from_Arwa_Thesis.pdf
_version_ 1848877875705413632
author Mostafa, Arwa Mohamed Amin
author_facet Mostafa, Arwa Mohamed Amin
author_sort Mostafa, Arwa Mohamed Amin
building USM Institutional Repository
collection Online Access
description Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome.
first_indexed 2025-11-15T17:22:24Z
format Thesis
id usm-36317
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T17:22:24Z
publishDate 2016
recordtype eprints
repository_type Digital Repository
spelling usm-363172019-04-12T05:25:32Z http://eprints.usm.my/36317/ The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing Mostafa, Arwa Mohamed Amin RM Therapeutics. Pharmacology Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome. 2016 Thesis NonPeerReviewed application/pdf en cc_by http://eprints.usm.my/36317/1/24Pages_from_Arwa_Thesis.pdf Mostafa, Arwa Mohamed Amin (2016) The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing. PhD thesis, Universiti Sains Malaysia.
spellingShingle RM Therapeutics. Pharmacology
Mostafa, Arwa Mohamed Amin
The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title_full The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title_fullStr The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title_full_unstemmed The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title_short The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
title_sort personalization of clopidogrel antiplatelet therapy in coronary artery disease patients using pharmacometabonomics, pharmacogenetics and platelets function testing
topic RM Therapeutics. Pharmacology
url http://eprints.usm.my/36317/
http://eprints.usm.my/36317/1/24Pages_from_Arwa_Thesis.pdf